Ledger.Open graph →
SEC Form D · filed November 10, 2022

TriSalus Life Sciences, Inc

Offering
$42.1M
Sold
$15.3M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
WESTMINSTER, CO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Simone Song · Westminster, CODirectorDiane Parks · Westminster, CODirectorGene Mcgrevin · WESTMINSTER, CODirectorJohn L. Tullis · Westminster, CODirectorSean Murphy · Westminster, COExec · DirectorAnil Singhal · WESTMINSTER, CODirectorKerry Hicks · Westminster, CODirectorMary T. Szela · Westminster, COExec · DirectorMats L. Wahlstrom · WESTMINSTER, CODirectorChristopher T. Ladd · Bentonville, ARDirectorStefan T. Sterns · Bentonville, ARDirectorKyle J. Charters · Durham, NCDirectorShaun Madden · Bend, ORDirectorS. James Miller Jr · Bend, ORDirectorDean D. Varner · TAMPA, FLDirectorEva Maglis · Toronto, Ontario, CanadaExec · DirectorElisabeth Cullington · Bend, ORExec · DirectorMark A. Buis · Southfield, MIDirectorMark Mccurdy, M.D · Fort Worth, TXExec · DirectorAjith Pai · Fort Worth, TXDirectorJulie Elsey · Fort Worth, TXDirectorWilliam Crawford · Fort Worth, TXDirectorRebecca Tucker · Fort Worth, TXDirectorBrett Truka · Chula Vista, CAExec · DirectorNehemiah R. Stewart · Chapel Hill, NCDirectorZachary D. Schrank · Chapel Hill, NCDirectorSignalfire Xir Venture Fund Ii GP, L.L.C · SAN FRANCISCO, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗